G21

G21 is an Italian medical device company that specializes in the development and manufacture of advanced biomaterials for orthopedics and neurosurgery. The company is a global leader in bone cements and delivery systems, providing solutions for joint replacement, vertebral augmentation, and infection management. Its flagship products include the Synicem bone cements and the SpaceFlex line of modular cement spacers for hip, knee, and shoulder revisions. G21 operates a state-of-the-art manufacturing facility in Italy and distributes its products in over 50 countries. In 2022, the company was acquired by Corin Group, a global leader in orthopedic technology, to expand its portfolio of biomaterial solutions.